FDA Granted Orphan Drug Designation to IMP4297+TMZ for SCLC
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Goby Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on...
/PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
SHANGHAI, March 14, 2022 /PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-